‘Green Light’ on Daewoong Pharmaceutical with Nabota’s USAN registration
Daewoong Pharmaceutical(CEO Jong-Wook Lee) announced a U.S. medical substance name for ‘Nabota,’ a botulinum toxin, was registered as ‘prabotulinumtoxin A.’
The USAN(United States Adopted Names) is one of the international drug names, officially sponsored by the American Medical Association(AMA)...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
